Skip to search formSkip to main contentSkip to account menu

maltose tetrapalmitate

Known as: D-Glucose, 4-O-alpha-D-glucopyranosyl-, tetrahexadecanoate, maltose tetrapalmitate (MTP) 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glycolipids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Angiogenesis and breast cancer.
1993
1993
The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in… 
1989
1989
Prophylactic antiangiogenic tumor treatment.
Complementary antitumor treatments are required to increase the cure rate achieved by surgery and/or radiotherapy by avoiding… 
1988
1988
Prophylactic maltose tetrapalmitate and bacillus Calmette-Guerin immunotherapy of recurrent superficial bladder tumors: preliminary report.
1986
1986
Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations… 
1985
1985
Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
1984
1984
Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma… 
1984
1984
Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
The prophylactic effect of maltose tetrapalmitate (MTP), a newly developed non specific immunoadjuvant in preventing or delaying… 
1983
1983
A comparative study of the intravesical MTP and BCG treatment of transplantable bladder cancer.
1980
1980
The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)